Study seeks to disprove cephalosporin allergies
Jul. 7, 2022—A Vanderbilt study shows that taking a careful history in patients who report allergies to cephalosporins and separating them into risk categories can help identify which patients are at low risk to be truly allergic to these antibiotics.
Study finds azithromycin use during RSV not useful in preventing recurrent wheezing, may cause harm
Feb. 28, 2022—Vanderbilt research on the impact of the antibiotic azithromycin during severe respiratory syncytial virus (RSV) bronchiolitis overwhelmingly support current national bronchiolitis guidelines, which recommend against antibiotics during acute bronchiolitis due to lack of effect on the acute illness.
Study finds shorter treatment better for young children with outpatient pneumonia
Feb. 3, 2022—A Vanderbilt study found that five days of antibiotics is superior to 10 days for children with community-acquired pneumonia who are not hospitalized.
Antimicrobial stewardship effort expanding reach
Nov. 18, 2021—The Vanderbilt Antimicrobial Stewardship Program recently expanded to the outpatient realm to provide more support for providers to optimize antibiotic use and delivery in the clinic setting.
Frog peptides as anti-HIV microbicides
Nov. 2, 2020—Peptides derived from the antimicrobial peptides secreted by frogs could function as microbicides to limit HIV transmission, while sparing protective vaginal bacteria.
Treating appendicitis with antibiotics instead of surgery may be good option for some, but not all, patients
Oct. 5, 2020—Antibiotics instead of surgery may be a good choice for some, but not all, patients with appendicitis, according to results from a study reported today in the New England Journal of Medicine.
Katz awarded LEAP Fellowship to improve antibiotic use in Tennessee
Apr. 9, 2020—Sophie Katz, MD, MPH, is one of four early career infectious diseases physicians in the United States to receive the award, which provides $100,000 of funding support from the Centers for Disease Control and Prevention.
Effort to remove penicillin allergy labels seeing success
Oct. 17, 2019—A program in the Medical Intensive Care Unit has successfully removed penicillin allergy labels from more than 45 inpatients at high risk to receive antibiotics, but whose penicillin allergies were low risk.
New test assists physicians with quicker treatment decisions for sepsis
Oct. 3, 2019—Rapid blood culture diagnostics for patients with bacterial bloodstream infections delivered final results in 12 hours versus the two to three days required for conventional testing.
Gene identified that increases risk of antibiotic reaction
Feb. 28, 2019—Researchers at Vanderbilt University Medical Center and colleagues have identified a gene that increases the risk for a severe and potentially life-threatening reaction to the commonly prescribed antibiotic vancomycin.
New staph virulence factor
Jun. 28, 2018—Jun. 28, 2018—The new factor, an enzyme involved in host-pathogen interactions, may be a viable target for treating staph infections.
Records point to drug-drug interaction
May. 7, 2018—Patients who take a cholesterol-lowering statin drug while taking the antibiotic daptomycin have increased risk of developing muscle weakness or a more severe form of muscle damage.